L

Lucid Diagnostics Inc
NASDAQ:LUCD

Watchlist Manager
Lucid Diagnostics Inc
NASDAQ:LUCD
Watchlist
Price: 1.15 USD -3.36% Market Closed
Market Cap: $150.6m

Wall Street
Price Targets

LUCD Price Targets Summary
Lucid Diagnostics Inc

Wall Street analysts forecast LUCD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LUCD is 3.87 USD with a low forecast of 2.53 USD and a high forecast of 8.66 USD.

Lowest
Price Target
2.53 USD
120% Upside
Average
Price Target
3.87 USD
236% Upside
Highest
Price Target
8.66 USD
653% Upside
Lucid Diagnostics Inc Competitors:
Price Targets
ATC
Arctic Paper SA
42% Upside

Revenue
Forecast

N/A
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Lucid Diagnostics Inc's revenue for the next 4 years is 77%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-71%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-71%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LUCD's stock price target?
Price Target
3.87 USD

According to Wall Street analysts, the average 1-year price target for LUCD is 3.87 USD with a low forecast of 2.53 USD and a high forecast of 8.66 USD.

What is Lucid Diagnostics Inc's Revenue forecast?
Projected CAGR
77%

The compound annual growth rate of Lucid Diagnostics Inc's revenue for the next 4 years is 77%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett